2 years ago
CABA
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Bottom 5%
#4876 out of 5121 analysts
Average Return
-8.05%
Win Rate
39%21 out of 54
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphic Holding IncMORF | +109.75% | $27.17 | $56.99 | 2023-12-08 - 2024-08-16 | Strong Buy |
Larimar Therapeutics IncLRMR | +103.34% | $3.29 | $6.69 | 2023-11-17 - 2024-11-15 | Strong Buy |
Immunovant IncIMVT | +78.11% | $16.17 | $28.80 | 2023-04-25 - 2024-04-24 | Strong Buy |
Argenx SeARGX | +66.54% | $549.65 | $915.36 | 2025-05-09 - 2025-12-02 | Strong Buy |
Roivant Sciences LtdROIV | +62.23% | $12.39 | $20.10 | 2025-09-02 - 2025-12-02 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
2 years ago
EDIT
2 years ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | 1 | Strong Buy | $102.00 | +85.96% | Initiates Coverage On | 7 days ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $38.00 | +40.85% | Initiates Coverage On | 7 days ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $136.00 | +34.14% | Initiates Coverage On | 8 days ago |
Argenx SeARGX | 7 | Strong Buy | $1,124.00 | +22.79% | Maintains | 16 days ago |
Biohaven LtdBHVN | 2 | Strong Buy | $14.00 | +58.55% | Maintains | 20 days ago |
Prime Medicine IncPRME | 5 | Hold | $4.25 | +28.79% | Maintains | 22 days ago |
Roivant Sciences LtdROIV | 3 | Strong Buy | $26.00 | +29.35% | Maintains | 22 days ago |
Catalyst Pharmaceuticals IncCPRX | 3 | Strong Buy | $33.00 | +45.89% | Maintains | a month ago |
Bioage Labs IncBIOA | 5 | Strong Buy | $15.00 | +76.68% | Maintains | a month ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Sell | $5.00 | -60.06% | Downgrades | a month ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $10.00 | +327.35% | Maintains | 4 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $16.00 | +128.90% | Initiates Coverage On | 5 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | +198.51% | Maintains | 7 months ago |
Structure Therapeutics IncGPCR | 1 | Strong Buy | $60.00 | +86.80% | Initiates Coverage On | 7 months ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | +32.16% | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $80.00 | N/A | Reinstates | 2 years ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.